Pharma
Sphere Fluidics wins The Life Science Company Of The Year Award from the Cambridge Independent
The Cambridge Independent awards were held on the 16th of May 2024, where we were proudly finalists for 2 very prestigious awards: 'Employer of the Year' and 'Life Science Company of the Year'. Being nominated for either of these awards is a great honor for all the team at Sphere Fluidi...
Chariots of Fire 2024
Chariots of Fire race officially launched for 2024 to support local air ambulance charity, Magpas Air Ambulance Cambridge, UK. ...
Mills & Reeve welcomes new partners in East Anglia
Mills & Reeve’s partnership continues to grow with 11 new promotions on 1 June 2024, four of which are based in East Anglia. ...
SPT Labtech and Watchmaker Genomics partner to simplify and streamline NGS library preparation
Automated protocols now available for mRNA and DNA sequencing.
Discover the ideal co-working space at Turing Locke
Looking for a refreshing change of scenery for your hybrid work routine? Turing Locke offers the perfect co-working space catering to both hotel guests and walk-in visitors for free. Whether you're a freelancer, a remote worker, or part of a team, our space is designed to enhance your p...
Turing Locke Open Day
Join Us at Turing Locke for Our Open Day!
Guardtech’s revamped three-part aftercare focus ensures all your cleanroom bases are covered
Suffolk-based construction experts offering elite Service Agreements, Decontamination programmes and cleanroom-grade furniture & equipment as part of their holistic packages ...
UK proteostasis community comes together for a successful inaugural event
The UK’s proteostasis community came together for the first event of the UK Proteostasis Network at the Institute. ...
Cresset appoints new Non-Executive Director
Cresset, innovative provider of computational drug discovery and development solutions that accelerate research outcomes, have announced the appointment of Dale Curtis as Non-Executive Director. ...
Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
The socioeconomic impact of Multiple Sclerosis (MS) extends to various areas of a patient’s life including personal wellbeing and mental health, family life and planning, employment and the lives of caregivers, which is associated with a significant economic and societal burden. Advance...